Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
Syneron is a company that using artificial intelligence and biotechnology to address two significant global challenges.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
HealthTech Innovations is a spin-off of Hospital Germans Trias i Pujol and transforming medical care through virtual reality.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
Resistell is a antibiotic resistance test.
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
OTR Therapeutics is a biotechnology company developing platform-based treatments using modular RNA and delivery systems.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
Promise Bio utilizes AI to analyze epiproteomics for autoimmune diseases.
EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Curve develops an innovative screening platform.
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Pfizer has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Valneva received $215.0M in a Post Ipo Debt round. Pfizer's total known invested capital is $4.0B.
Pfizer's average investment size is $92.6M across its portfolio of 100 companies.
Recent Pfizer portfolio additions include Enodia Therapeutics, Syneron, NextCure, 4D Molecular Therapeutics, HealthTech Innovations. These companies were founded in 2020 or later.